Medicus Pharma (MDCX) Receivables (2025)
Medicus Pharma's (MDCX) quarterly Receivables came in at $374640.0 in Q2 2025, up 2576.0% on a QoQ basis from $14000.0 in Q1 2025.
Medicus Pharma (MDCX) Receivables (2025) Analysis & Trends
Medicus Pharma (MDCX) has 1 years of Receivables data on file, last reported at $374640.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 14.33 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 5.90 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 10.34 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 374,640.00 |
| Mar 31, 2025 | 14,000.00 |